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Safety of Nurse-administered Propofol Sedation
Using PCA Pump for Outpatient Colonoscopy 
in Chinese Patients: A Pilot Study
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BACKGROUND: To determine the safety and effectiveness of nurse-administered propofol sedation
using patient-controlled analgesia (PCA) pump in outpatient colonoscopy in a Chinese population.
METHODS: From April to June 2005, 50 consecutive ASA class I or II patients aged 18–65 undergoing
outpatient colonoscopy in an endoscopy centre of a regional hospital were prospectively recruited in this
study. After a loading dose of 40–60 mg intravenous propofol, a mixture containing 14.3 mg propofol
and 35 µg alfentanil were delivered via a patient-controlled syringe pump as bolus dose by an endoscopy
nurse under the supervision of an endoscopist during the procedure. Lockout time was set to be zero. We
aimed to achieve conscious sedation, with an Observer’s Scale for Sedation and Alertness (OSSA) score of 3.
The primary outcome measure was complications from sedation, which included hypotension, bradycar-
dia and desaturation. Other outcome measures included onset time, patients’ pain score, endoscopists’
and nurses’ satisfaction on the level of sedation, patients’ satisfaction regarding the procedure (measured
by 10 cm visual analogue scale), and their willingness to repeat the procedure.
RESULTS: The mean lowest systolic blood pressure and mean arterial pressure (MAP) were 103.2 ±
12.4 mmHg and 78.3 ± 11.0 mmHg, respectively. The mean percentage drop in MAP was 15.7 ± 11.9%. Six
patients (12.2%) developed transient hypotension. Three patients (6.1%) had bradycardia. There was no
episode of desaturation. The median onset time to reach OSSA score of 3 was 1 minute (range, 0.5–20.5).
The OSSA score of 3 could be maintained throughout the procedure. The mean loading dose of propofol
was 48.9 ± 6.7 mg. The mean total dosages of propofol and alfentanil given were 124.2 ± 38.1 mg and
184.3 ± 93.7 µg, respectively. Endoscopists, endoscopy nurses and patients were highly satisfied with the
sedation. The median pain score was 1 (range, 0–10; 0 = no pain, 10 = very painful), and the mean recovery
time was 2.8 ± 2.8 minutes. Most patients (93.9%) were willing to repeat the procedure.
CONCLUSION: Nurse-administered propofol sedation using PCA pump is safe and effective in seda-
tion and pain control in outpatient colonoscopy in a healthy Chinese population. [Asian J Surg 2007;
30(4):239–43]
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Introduction
Propofol has been reported as a choice of sedation for
endoscopy in recent years.1 Its characteristics of rapid
onset, short half-life and rapid recovery compared with
traditional intravenous sedation are advantageous as 
a hypnotic agent in the outpatient setting.2 Its unpopu-
larity in the past is accounted for by the absence of an
antidote, adverse effects of hypotension and severe respi-
ratory depression. In the consideration of safety, propofol
used to be administered by anaesthesiologists in Hong
Kong. Recent studies have successfully showed that nurse-
administered propofol sedation (NAPS) under the super-
vision of endoscopists without anaesthesiologists is safe
and effective.3–7 In past studies, propofol was delivered by
intravenous bolus and titrated against the level of sedation.
This requires a demanding technique of drug administra-
tion and close patient monitoring. Patient-controlled anal-
gesia (PCA) pump has been used for patient-controlled
sedation in colonoscopy in the past. Based on the proper-
ties of concise repeated drug delivery and constant time
interval between doses with the use of a PCA pump, we
propose that it can facilitate NAPS. A new protocol on NAPS
using PCA pump has been developed in our endoscopy
unit. This pilot study aims to investigate the safety and
effectiveness of NAPS by PCA pump in Chinese patients,
and its acceptance to endoscopy nurses.
Patients and methods
This study was supported by the Department of Anaesthesia.
All endoscopy nurses participating in this study have the
Basic Cardiac Life Support (BCLS) certificate and they are
familiar with initial airway management by chin lift ma-
noeuvre and oropharyngeal airway insertion. Before the
start of this study, endoscopists and endoscopy nurses
were trained by a consultant anaesthesiologist through 
a series of lectures to understand: (1) the properties and
technique of propofol delivery; (2) patient monitoring 
by using the Observer’s Scale for Sedation and Alertness
(OSSA) score (Table 1); and (3) a reminder on airway man-
agement. During the study period, a dedicated senior anaes-
thesiologist inside the hospital was immediately available
for assistance if necessary.
From April to June 2005, 50 consecutive patients aged
18 to 65 undergoing outpatient elective colonoscopy were
recruited for the trial with informed consent. Ethical
approval was obtained from the clinical research ethics
committee of the institution. Exclusion criteria included:
(1) American Society of Anesthesiologist (ASA) Class III
or above; (2) known allergy to propofol, alfentanil, eggs or
soy products; (3) previous colectomy; (4) history of difficult
endotracheal intubation.
We aimed to achieve the level of conscious sedation, or
moderate sedation/analgesia. Conscious sedation was
defined according to the ASA as a state of drug-induced
depression of consciousness during which patients respond
purposefully to verbal commands, either alone or accom-
panied by light tactile stimulation. No interventions were
required to maintain a patent airway, and spontaneous
ventilation is adequate. Cardiovascular function was usu-
ally maintained. Sedation was considered adequate when
the patient only responded to light tactile stimulation.
The patient was monitored by a qualified endoscopy
nurse with BCLS certification, in addition to the medical
and nursing staff required for the procedure. The nurse
provided verbal intercommunication to and from patients
with light tactile stimulation throughout the procedure.
The level of sedation was assessed every 30 seconds accord-
ing to OSSA score. The nurse pressed the button of the PCA
pump until an OSSA score of 3 was achieved. Propofol
(Diprivan®; AstraZeneca, Hong Kong SAR) and alfentanil
(Rapifen®; Janssen-Cilag, Hong Kong SAR) were delivered
intravenously via a 50 mL-syringe PCA pump (Grabesy
3300 PCA pump; Graseby Medical Ltd., Hertfordshire, UK)
by bolus titration. A loading dose of 40–60 mg propofol
or 0.8 mg propofol/kg, whichever was the higher, was given
1 minute before the commencement of the procedure.
Propofol 20 mL (200 mg) and alfentanil 1 mL (0.5 mg) were
mixed in a 50 mL-syringe pump and 1.5 mL of mixture
(14.3 mg propofol and 35 µg alfentanil) was delivered in
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Table 1. Observer’s Scale for Sedation and Alertness
Score Responsiveness Eyes
5 Responds readily to name Clear, no ptosis
4 Lethargic response to name Glazed or mild ptosis
(< 1/2 eye)
3 Responds only when called Marked ptosis 
loudly/repeatedly (> 1/2 eye)
2 Responds after mild
prodding/shaking
1 Unresponsive to mild
prodding/shaking
each bolus with zero lockout time. About 20 seconds was
required for completion of each bolus delivery. The nurse
stopped drug delivery and informed the endoscopist when
(1) an allergic reaction occurred, or (2) the patient developed
desaturation with SpO2 < 90%, or (3) the patient developed
hypotension (systolic blood pressure [SBP] < 90 mmHg)
or bradycardia (pulse < 50/min). The nurse informed the
patient on the finding of appendiceal opening when the
colonoscope reached the caecum. Drug delivery was stopped
on withdrawal of the colonoscope.
Hong Kong College of Anaesthesiologists guidelines
on sedation were followed.8 An anaesthesiologist was avail-
able on request during the procedure. The patient’s oxygen
saturation was continuously monitored by pulse oxime-
ter which was set to alarm when the saturation fell below
90%. Two litres of oxygen were routinely given via nasal
cannula. Blood pressure was measured every 3 minutes. In
patients with desaturation and reduced respiratory effort,
patent airway was maintained by the chin lift manoeuvre
and oropharyngeal airway. Colonoscopies were performed
by experienced endoscopists who have the experience of
300 similar procedures.
After the procedure, the patient was monitored in the
recovery area. Degree of alertness was assessed every 
5 minutes according to the OSSA score. When patients
had an OSSA score of 5, were haemodynamically stable
(SBP >90 mmHg and pulse >50/min) and ambulatory, they
were regarded as having fully recovered from the procedure.
At the end of the pilot study, a questionnaire was com-
pleted by the endoscopy nurses who participated in this
study. The usefulness of the PCA pump in NAPS was
assessed.
The primary outcome measure was complications aris-
ing from sedation, which included hypotension, bradycar-
dia and desaturation. Other outcome measures included
propofol onset time, patients’ pain score, endoscopists’
and nurses’ satisfaction on the level of sedation, patients’
satisfaction on the procedure, their memory on colonoscopy
findings and their willingness to repeat the procedure. All
scores were measured using a 10 cm visual analogue scale
(0 = unsatisfied, 10 = very satisfied).
Results
From April to June 2005, 50 consecutive patients were
recruited for the study; 23 were female and 27 were male.
Mean age was 47.6 ± 10.1 years, and 35 patients belonged
to ASA class I and 14 patients belonged to ASA class 2.
Eleven patients had previous history of colonoscopy. Indi-
cations for colonoscopy included per rectal bleeding (n=26),
abdominal pain (n = 7), altered bowel habit (n = 13), past
history of colonic polyp (n = 4) and anemia (n = 1).
All colonoscopies were completed with no complica-
tions. The mean duration of the procedure was 19.0 ±
8.6 minutes. The mean time to reach the caecum was
11.3 ± 5.4 minutes. The mean baseline SBP was 128.0 ±
17.9 mmHg and baseline mean arterial pressure (MAP)
was 93.9 ± 13.6 mmHg. The lowest SBP and MAP were
103.2 ± 12.4 mmHg and 78.3 ± 11.0 mmHg, respectively.
The mean percentage drop in MAP was 15.7 ± 11.9%. Six
patients (12.2%) developed transient hypotension (SBP
< 90 mmHg) during the procedure, with the lowest SBP
being 78 mmHg. All patients regained normal blood pres-
sure spontaneously on repeated measurement after drug
delivery was stopped temporarily. No patients required
intravenous fluid resuscitation. Thirteen patients (26.5%)
had a greater than 25% drop in MAP. Three patients (6.1%)
had bradycardia (pulse < 50/min). There was no episode
of desaturation. The mean lowest SpO2 was 97.0 ± 2.5%.
The mean OSSA score at the beginning of the procedure
1 minute after the loading dose was 3.45 ± 1.4. The median
onset time to reach OSSA score of 3 was 1 minute (range,
0.5–20.5 minutes). The OSSA score of 3 could be main-
tained throughout the procedure. The mean OSSA score
from the start of the procedure to the arrival of the colono-
scope at the caecum was 3.24 ± 0.57. The mean OSSA score
at the caecum was 2.86 ± 1.18. The mean loading dose of
propofol was 48.9 ± 6.7 mg. The mean total dosages of
propofol and alfentanil given were 124.2 ± 38.1 mg and
184.3 ± 93.7 µg, respectively.
We achieved high endoscopists’ and nurses’ satisfac-
tion on sedation (0 = unsatisfied, 10 = very satisfied). Mean
endoscopist’s satisfaction score was 7.5 ± 2.4 and mean
nurse’s satisfaction score was 7.78 ± 2.2. Mean patient’s
satisfaction score was 8.6 ± 1.9 and the median pain score
was 1 (range, 0–10; 0 = no pain, 10 = very painful). Most
patients (46/50, 92%) were willing to repeat the procedure
with the same mode of sedation. The mean recovery time
was 2.8 ± 2.8 minutes. Of the 50 patients, 38 (76%) could
recall the colonoscopy findings. No patients required
overnight observation. Seven endoscopy nurses dedicated to
NAPS filled in the questionnaire. All of them preferred
sedation in colonoscopy. They were competent in patient
monitoring and assessment of complications. Most of
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them (6 of 7) preferred PCA pump to manual injection for
drug delivery. They all agreed that the PCA pump could
reduce their burden in NAPS.
Discussion
This is the first study to describe the use of a PCA pump
in NAPS. The PCA pump is commonly used in patient-
controlled sedation (PCS) in colonoscopy.1,9–11 It has sev-
eral advantages compared with conventional manual bolus
titration by syringe injection. First, it can accurately give
the same bolus dose repeatedly. Nurses need not pay atten-
tion to the dose they inject each time, so human error can
be avoided. Second, the time interval between bolus injec-
tions is fixed to around 20 seconds by the machine with
zero lockout time for drug delivery. This is an ideal window
between bolus doses. Nurses who deliver the drug need
not count the time before delivering the next dose. Thus,
they can comfortably concentrate on the assessment of
the patient response and monitoring of blood pressure
and SpO2.
The level of sedation and pain control determine the
success of a comfortable colonoscopy. Previous studies 
in NAPS used a loading dose of 20–50 mg followed by 
a bolus dose of 10–20 mg propofol without alfentanil
(Table 2). Studies in the United States use no analgesia,
while studies in Switzerland add 12.5–25 mg meripidine
for pain control. In our new protocol, a relatively higher
loading dose (mean, 48.9 mg) was used, with an excellent
median onset time of 1 minute, just at the beginning of
the procedure. The propofol/alfentanil mixture is effective
in sedation and pain control. A state of conscious seda-
tion (OSSA score 3) can be kept during the procedure, while
a low median pain score of 1 can be achieved. Both the
synergistic effect of alfentanil and no-drug-delivery strategy
on withdrawal of the colonoscope contributed to the low
mean total dose of propofol of 124.2 mg compared with
other studies (Table 2). The latter factor also contributed
to a short recovery time.
The potential danger of cardiopulmonary compli-
cation in the absence of an antidote makes physicians
extremely cautious in the use of propofol without anaes-
thesiologists. The most life-threatening event is reduced
respiratory effort, leading to desaturation and respiratory
arrest. Close patient monitoring and strong support from
an anaesthesiologist are essential to develop a safe prac-
tice of NAPS. This will inevitably increase the demands on
resources and manpower. In our protocol, one extra
endoscopy nurse with BCLS certification is required in
each endoscopy room. Despite the extra cost of NAPS, the
favourable outcome of a high quality colonoscopy service
can be achieved. If the resources are available, NAPS is 
a good choice to make colonoscopy a comfortable proce-
dure, with an optimal sedation and a low pain score.
We encountered 12.2% transient hypotension and 6.1%
bradycardia. There was no respiratory complication in
our series. All patients with hypotension did not require
fluid resuscitation. The ultra-short half-life of propofol
can readily remedy the disadvantage of there being no
antidote. Our result is comparable to previous NAPS stud-
ies, with 0–22% hypotension and 0.1–3.7% desaturation.4–8
The addition of alfentanil does not hinder the safety of
NAPS, but gives better pain control. NAPS is highly accepted
by patients, endoscopists and nurses. Most endoscopists,
endoscopy nurses and patients were satisfied with our
new protocol of NAPS. In particular, endoscopy nurses
appreciate the use of the PCA pump, which can reduce
their burden. Most patients (92%) were willing to repeat
the procedure with the same mode of sedation.
To conclude, our new protocol using PCA pump in
NAPS for outpatient colonoscopy is safe and effective in
sedation and pain control with fast recovery in healthy
Chinese patients. It is well accepted by patients, endoscopy
nurses and endoscopists in Chinese population. Further
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Table 2. Dosage of propofol in nurse-administered propofol sedation
Loading dose (mg) Bolus dose (mg) Time interval between doses (sec) Mean total dose (mg)
Sipe et al3 20–40 10–20 30–60 218
Kulling et al4 0.5/kg (half in ASA 10 30–60 157
3/4, age > 70)
Heuss et al5 20 10 20 1.93/kg
Walker et al7 30–50 10–20 30–60 210
randomized trial of NAPS versus conventional sedation is
worthwhile before commencing routine use of NAPS with
PCA pump in outpatient colonoscopy.
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